is retatrutide same as ozempic vs Tirzepatide: Which Weight-Loss Drug Better? Retatrutide: The Unapproved Drug America
Description
Clinical studies of FDA-approved semaglutide products have demonstrated effects on weight management and metabolic markers in appropriate patients
Researchers tested the triple-dose of semaglutide in two clinical trials, one involving people with obesity and the other in people with obesity and type 2 diabetes
A possible reason is the short duration of treatment
4 Cardiovascular Risk Reduction In addition to managing blood glucose levels and promoting weight loss, GLP-1 receptor agonists have been found to reduce the risk of cardiovascular events, which is a critical consideration in diabetic patients
Common side effects include dizziness, fatigue, gastrointestinal issues, headaches, and stomach problems
